SENORES logo

Senores Pharmaceuticals NSEI:SENORES Stock Report

Last Price

₹572.90

Market Cap

₹26.4b

7D

n/a

1Y

n/a

Updated

02 Jan, 2025

Data

Company Financials

Senores Pharmaceuticals Limited

NSEI:SENORES Stock Report

Market Cap: ₹26.4b

SENORES Stock Overview

Develops, manufactures, and sells, pharmaceutical products in India, the United States, Canada, and internationally. More details

SENORES fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance1/6
Financial Health3/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

Senores Pharmaceuticals Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for Senores Pharmaceuticals
Historical stock prices
Current Share Price₹572.90
52 Week High₹609.65
52 Week Low₹538.85
Beta0
1 Month Changen/a
3 Month Changen/a
1 Year Changen/a
3 Year Changen/a
5 Year Changen/a
Change since IPO2.85%

Recent News & Updates

Recent updates

Shareholder Returns

SENORESIN PharmaceuticalsIN Market
7Dn/a3.1%0.5%
1Yn/a36.2%17.4%

Return vs Industry: Insufficient data to determine how SENORES performed against the Indian Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how SENORES performed against the Indian Market.

Price Volatility

Is SENORES's price volatile compared to industry and market?
SENORES volatility
SENORES Average Weekly Movementn/a
Pharmaceuticals Industry Average Movement5.9%
Market Average Movement6.2%
10% most volatile stocks in IN Market9.0%
10% least volatile stocks in IN Market4.1%

Stable Share Price: SENORES's share price has been volatile over the past 3 months compared to the Indian market.

Volatility Over Time: Insufficient data to determine SENORES's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
2017113Swapnil Shahsenorespharma.com

Senores Pharmaceuticals Limited develops, manufactures, and sells, pharmaceutical products in India, the United States, Canada, and internationally. The company offers tablets, capsules, liquids, dry syrups, oral rehydration solutions, active pharmaceutical ingredients, and critical care injectables, including antibiotics, anti-bacterial, anti-fungal, and blood line. It also exports its products.

Senores Pharmaceuticals Limited Fundamentals Summary

How do Senores Pharmaceuticals's earnings and revenue compare to its market cap?
SENORES fundamental statistics
Market cap₹26.38b
Earnings (TTM)₹314.55m
Revenue (TTM)₹2.15b

83.9x

P/E Ratio

12.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
SENORES income statement (TTM)
Revenue₹2.15b
Cost of Revenue₹1.09b
Gross Profit₹1.06b
Other Expenses₹742.15m
Earnings₹314.55m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)6.83
Gross Margin49.26%
Net Profit Margin14.66%
Debt/Equity Ratio107.2%

How did SENORES perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/02 03:52
End of Day Share Price 2025/01/02 00:00
Earnings2024/03/31
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Senores Pharmaceuticals Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution